Wet (Neovascular) Age-Related Macular Degeneration
Description: Clinical trial evaluating whether supplementing existing anti-VEGF treatment with a new drug that blocks additional forms of VEGF (a natural chemical which promotes swelling in the retina) will improve treatment response in wet age-related macular degeneration.
Full Title: Phase 3 Multicentre, Double-Masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participants with Neovascular Age-Related Macular Degeneration
Sponsor: Opthea Limited
Principal Investigator: Scott McClintic, MD
Study Coordinator: Kimberly Flora, NCMA
Status: Actively Enrolling